StonvexLoading…
StonvexStonvexStonvexCore line items from CAG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-05-25 | Annual 2024 2024-05-26 | Annual 2023 2023-05-28 | Annual 2022 2022-05-29 |
|---|---|---|---|---|
Revenue | $11.61B | $12.05B | $12.28B | $11.54B |
Operating Income | $1.36B | $852.80M | $1.08B | $1.59B |
Net Income | $1.15B | $347.20M | $683.60M | $888.20M |
EPS (Diluted) | $2.40 | $0.72 | $1.42 | $1.84 |
Total Assets | $20.93B | $20.86B | $22.05B | $22.44B |
Total Liabilities | $12.00B | $12.35B | $13.25B | $13.57B |
Cash & Equivalents | $68.00M | $77.70M | $93.30M | $83.30M |
Free Cash Flow OCF − CapEx | $1.30B | $1.63B | $633.20M | $712.90M |
Shares Outstanding | 479.70M | 480.00M | 480.70M | 482.20M |